Literature DB >> 8562168

Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells.

H D Orzechowski1, C Beckenbach, H Herbst, U Stölzel, E O Riecken, A Stallmach.   

Abstract

There is increasing evidence that the expression of variants of the glycoprotein CD44 is related to the invasive and metastatic potential of tumour cells. By in situ hybridisation, we analysed the cellular expression of human homologues of a rat metastasis-associated CD44 variant v6 in invasive and non-invasive colorectal neoplasia and normal colonic mucosa. No specific hybridisation signals could be detected in epithelial cells of the normal crypt (n = 10). In contrast, we found moderate epithelial hybridisation signals in adenomatous polyps of mild dysplasia (n = 6). Adenoma cells of moderate or severe dysplasia (n = 7) showed increased hybridisation signals compared to mildly dysplastic adenomas (P < or = 0.01). We could not demonstrate significant differences in CD44v6 transcript levels between cells of dysplastic adenoma and primary adenocarcinoma (n = 11) (P > or = 0.05). Furthermore, we were not able to demonstrate a significant difference between primary and metastatic tumours (n = 7) (P > or = 0.05). However, there was a significant difference between metastatic carcinoma and adenomas with advanced dysplasia (P < or = 0.01). Our data demonstrate that significant transcriptional expression of CD44v6 is not confined to invasive tumour cells, but is already detectable in cells of adenomatous polyps showing mild dysplasia. The results of this study show a close relationship between cellular dysplasia and steady state levels of CD44 variant v6 transcripts in colorectal neoplasms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562168     DOI: 10.1016/0959-8049(95)00452-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.

Authors:  A Stallmach; C C Chan; K W Ecker; G Feifel; H Herbst; D Schuppan; M Zeitz
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

2.  CD44 variant exons in leukemia and lymphoma.

Authors:  Elif Akisik; Sevil Bavbek; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 3.  CD44 and HCELL: preventing hematogenous metastasis at step 1.

Authors:  Pieter P Jacobs; Robert Sackstein
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

4.  Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis.

Authors:  F Hallouin; C Goupille; M le Cabellec; J Bara; J le Pendu
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

5.  Expression of CD44s in human colorectal cancer.

Authors:  Mousa Khoursheed; T C Mathew; R R Makar; L Sonia; H Abul; S Asfar; H Al-Sayer; H M Dashti; A Al-Bader
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

6.  CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.

Authors:  Lili Wang; Qin Liu; Dongliang Lin; Maode Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.

Authors:  D Masson; M G Denis; P Lustenberger
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

8.  Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.

Authors:  Elmire Hartmans; Veronique Orian-Rousseau; Alexandra Matzke-Ogi; Arend Karrenbeld; Derk Jan A de Groot; Steven de Jong; Gooitzen M van Dam; Rudolf S N Fehrmann; Wouter B Nagengast
Journal:  Theranostics       Date:  2017-01-06       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.